newsfilter
← Latest News
Business Wire·

Maravai Lifesciences Reports Fourth Quarter and Full Year 2025 Financial Results

Organizational restructuring and operating cost reduction ahead of plan Focus on operational excellence, revenue growth, and improving Adjusted EBITDA Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ:MRVI), a